Different caveolin isoforms in the retina of melanoma malignum affected human eye

Ida Ágnes Berta, Anna L. Kiss, Ádám Kemény-Beke, Ákos Lukáts, Arnold Szabó, Ágoston Szél

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose: Caveolin-1 has been identified in Müller and pigment cells of rodents, but the distribution of caveolin isoforms has not been studied in the human retina. Since there are no relevant data in humans, we aimed to study the distribution of caveolins in the human retina. Methods: Our samples were derived from eyes affected by melanoma malignum choroideae that were enucleated. The distribution of the caveolins was examined by immunocytochemistry using isoform-specific antibodies. Results: In this study we report on the presence of different caveolin isoforms in many cell types of the human retina. These isoforms were present in several regions and layers in the human retina. Centro-peripheral changes have been detected: the distribution altered following the radier direction. Conclusions: This is the first demonstration of caveolin expression in the human retina. Our data suggest that caveolins play an important role in the function of retinal cells. Our observations refute previous assumptions that there is a shortage of caveolins in the retina. Since the retina contains a number of different neuronal and glial cell types, the caveolin expression of these cells can no longer be a matter of dispute.

Original languageEnglish
Pages (from-to)881-886
Number of pages6
JournalMolecular Vision
Volume13
Publication statusPublished - Jun 15 2007

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Different caveolin isoforms in the retina of melanoma malignum affected human eye'. Together they form a unique fingerprint.

  • Cite this

    Berta, I. Á., Kiss, A. L., Kemény-Beke, Á., Lukáts, Á., Szabó, A., & Szél, Á. (2007). Different caveolin isoforms in the retina of melanoma malignum affected human eye. Molecular Vision, 13, 881-886.